In 2007, a groundbreaking medical case reshaped the global fight against HIV when a patient with both advanced leukemia and the virus became the first person ever declared cured of HIV. The unexpected success emerged from a last resort cancer therapy that doctors had not designed to target HIV at all, yet it opened a new chapter in infectious disease medicine.
The patient, later known as the Berlin Patient, received a bone marrow transplant to treat his leukemia. His doctors at Charite Hospital in Berlin selected a donor with a rare genetic mutation called CCR5-delta32, which naturally blocks HIV from entering immune cells. After the transplant, the patient’s leukemia went into remission and his HIV viral load became undetectable without antiretroviral drugs. He remained virus free for the rest of his life, proving that a cure was possible.
This single case rewrote medical understanding of HIV. Before 2007, the virus was considered incurable because it hides in dormant cells and reactivates if treatment stops. The Berlin Patient’s outcome showed that replacing a person’s immune system with HIV resistant cells could eliminate the virus entirely. Since then, two more patients, the London Patient and the Dusseldorf Patient, have been cured using the same approach. However, the procedure remains high risk and is only used for people who also need a bone marrow transplant for blood cancers.
Researchers have since built on this breakthrough to explore safer strategies. Gene editing tools like CRISPR are now being tested to create the CCR5 mutation in a patient’s own cells without needing a donor. Clinical trials are underway to see if this can provide a functional cure for more people living with HIV. While the transplant method itself is not suitable for the millions on antiretroviral therapy, the 2007 case proved that a cure is not a myth but a medical reality waiting to be refined.
What began as a desperate attempt to save a cancer patient became the foundation of an entirely new field of HIV cure research. Today, scientists are closer than ever to translating that one extraordinary result into treatments that could one day reach far beyond the transplant ward.